Escitalopram Oxalate
Product Images NDC 67046-174

This table provides a list of treatment-emergent adverse reactions observed in patients with major depressive disorder and treated with Escitalopram Oxalate. The adverse reactions are grouped into categories including autonomic nervous system disorders, central, and peripheral nervous system disorders, gastrointestinal disorders, general, psychiatric disorders, respiratory system disorders, and urogenital. The frequency of each reaction is compared to placebo. The table also includes denominators for males and females separately, and a note clarifying the meaning of the term "primarily ejaculatory delay".*

The text describes a table showing the treatment-emergent adverse reactions observed with a frequency of greater than 2% and more than the placebo for individuals with Generalized Anxiety Disorder. The table lists the adverse reactions observed for the drug Escitalopram compared to the placebo for different organ systems, such as the Autonomic Nervous System, Central & Peripheral Nervous System, Gastrointestinal Disorders, Psychiatric Disorders, etc. The reactions include Dry Mouth, Sweating Increased, Headache, Paresthesia, Nausea, Diarthea, Constipation, etc. The table also lists the frequency of Ejaculation Disorder, Anorgasmia, Menstrual Disorder, and other reactions.*

Escitalopram is a prescription medication used to treat anxiety and depression. The usual dosage can be found in the accompanying prescribing information. The medication is packaged by Contract Pharmacy Services-PA and contains 20mg of escitalopram oxalate per film-coated tablet. The lot number is 4DD4C086 and the expiration date is 06/15/18. The medication should be stored at a temperature between 20-25°C (68-77°F).*